FDA clears first "special" 510(k)
This article was originally published in The Gray Sheet
Executive Summary
Casco Standards receives clearance April 24 for its lactate ammonia ethanol calibrator, agency staffers say. Under the special 510(k) program, companies can submit certification of compliance with quality systems requirements in lieu of data for a device modification. FDA's okay comes 10 days after the firm submitted to the Division of Clinical Laboratory Devices in the agency's Office of Device Evaluation a premarket notification covering a device modification. At least four of the six divisions of ODE have received a special 510(k) under the program, which was finalized in March ("The Gray Sheet" March 23, p. 14)
You may also be interested in...
China VBP, Localization And Other Strategies - How Far And Which Way?
Could health sector players encounter issues similar to those facing Tesla in China, a country which virtually saved the electric vehicle maker but where it is now facing challenges? Are there any lessons to be learned from a success story under China's volume-based procurement scheme? A partner at EY looks at these and other issues in an interview with Scrip.
Ratio Therapeutics On BMS Investment, Radiopharma R&D Trends, AI Use
The CEO and CSO of radiopharmaceutical company Ratio Therapeutics, which now has Bristol Myers Squibb as an investor, talk about Ratio’s R&D platforms, use of AI, an independent FAP-targeted asset and trends in radiopharma research such as combining other modalities like ADCs, in this podcast interview with Scrip
With One Launch Under Way, SpringWorks Ramps Up For A Second
The company initiated a rolling submission with the US FDA for mirdametinib, a MEK inhibitor that is poised to be its second commercial product for a rare disease.